185 related articles for article (PubMed ID: 33442023)
1. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C
Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023
[TBL] [Abstract][Full Text] [Related]
2. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
Carlo MI; Mukherjee S; Mandelker D; Vijai J; Kemel Y; Zhang L; Knezevic A; Patil S; Ceyhan-Birsoy O; Huang KC; Redzematovic A; Coskey DT; Stewart C; Pradhan N; Arnold AG; Hakimi AA; Chen YB; Coleman JA; Hyman DM; Ladanyi M; Cadoo KA; Walsh MF; Stadler ZK; Lee CH; Feldman DR; Voss MH; Robson M; Motzer RJ; Offit K
JAMA Oncol; 2018 Sep; 4(9):1228-1235. PubMed ID: 29978187
[TBL] [Abstract][Full Text] [Related]
5. Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases.
Yngvadottir B; Andreou A; Bassaganyas L; Larionov A; Cornish AJ; Chubb D; Saunders CN; Smith PS; Zhang H; Cole Y; Research Consortium GE; Larkin J; Browning L; Turajlic S; Litchfield K; Houlston RS; Maher ER
Hum Mol Genet; 2022 Aug; 31(17):3001-3011. PubMed ID: 35441217
[TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma.
Han S; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
medRxiv; 2023 Jan; ():. PubMed ID: 36712083
[TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity.
Smith PS; West H; Whitworth J; Castle B; Sansbury FH; Warren AY; Woodward ER; Tischkowitz M; Maher ER
Genes Chromosomes Cancer; 2021 Jan; 60(1):5-16. PubMed ID: 32830346
[TBL] [Abstract][Full Text] [Related]
9. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.
Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP
Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Gleeson JP; Nikolovski I; Dinatale R; Zucker M; Knezevic A; Patil S; Ged Y; Kotecha RR; Shapnik N; Murray S; Russo P; Coleman J; Lee CH; Stadler ZK; Hakimi AA; Feldman DR; Motzer RJ; Reznik E; Voss MH; Chen YB; Carlo MI
Clin Cancer Res; 2021 May; 27(10):2910-2919. PubMed ID: 33658299
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma.
Feng H; Cao S; Ouyang Q; Li H; Li X; Chen K; Zhang X; Huang Y; Zhang X; Ma X
Transl Androl Urol; 2023 Feb; 12(2):308-319. PubMed ID: 36915884
[TBL] [Abstract][Full Text] [Related]
12. Trans-ethnic variation in germline variants of patients with renal cell carcinoma.
Abou Alaiwi S; Nassar AH; Adib E; Groha SM; Akl EW; McGregor BA; Esplin ED; Yang S; Hatchell K; Fusaro V; Nielsen S; Kwiatkowski DJ; Sonpavde GP; Pomerantz M; Garber JE; Freedman ML; Rana HQ; Gusev A; Choueiri TK
Cell Rep; 2021 Mar; 34(13):108926. PubMed ID: 33789101
[TBL] [Abstract][Full Text] [Related]
13. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
14. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
[TBL] [Abstract][Full Text] [Related]
15. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
Sekine Y; Iwasaki Y; Aoi T; Endo M; Hirata M; Kamatani Y; Matsuda K; Sugano K; Yoshida T; Murakami Y; Fukui T; Akamatsu S; Ogawa O; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
Hum Mol Genet; 2022 Jun; 31(12):1962-1969. PubMed ID: 35764097
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
18. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract][Full Text] [Related]
19. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
20. Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma.
Jafri M; Wake NC; Ascher DB; Pires DE; Gentle D; Morris MR; Rattenberry E; Simpson MA; Trembath RC; Weber A; Woodward ER; Donaldson A; Blundell TL; Latif F; Maher ER
Cancer Discov; 2015 Jul; 5(7):723-9. PubMed ID: 25873077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
